Table 2.
Effect of Flavo on heart and brain weight indices in cyclo-injected mice
| Groups | LDH (U/L) | CK-MB (U/L) | NO (µmol/L) |
|---|---|---|---|
| Control | 2886.25 ± 232.87 | 273.75 ± 14.097 | 40.75 ± 0.853 |
| Flavo | 3444.5 ± 218.5 | 305 ± 5.00 | 50.5 ± 1.500 |
| Cyclo | 9480.5 ± 89.553*$ | 584.25 ± 21.301$ | 75.25 ± 4.837*$ |
| Cyclo + Flavo | 1488.19 ± 107.67*$# | 240.8 ± 16.3111# | 29.4 ± 2.112$# |
Oral administration of (20 mg/kg) Flavocoxid (Flavo) to mice from day 0 to 14 followed by Cyclophosphamide (Cyclo) intraperitoneal i.p (100 mg/kg) at day 14. Data were expressed as mean ± SED (n = 10). *, $, #, significantly different when compared to normal control, Flavo and Cyclo groups, respectively, using one-way ANOVA test with Tukey Kramer post hoc test (p < 0.05)